Table 2.
Groups | Treatment | Dose (μg/kg) | MST 6 s.d. | P-value (versus Group I) |
---|---|---|---|---|
I (n= 10) | HBSS | 8.6 ± 1.5 | ||
II (n= 6) | Luffin P1 | 70 | 9.3 ± 1.2 | >0.05 |
III (n= 7) | hIL-2-Luffin P1 | 22.5 | 13.9 ± 2.1 | <0.001 |
Groups | Treatment | Dose (μg/kg) | MST 6 s.d. | P-value (versus Group I) |
---|---|---|---|---|
I (n= 10) | HBSS | 8.6 ± 1.5 | ||
II (n= 6) | Luffin P1 | 70 | 9.3 ± 1.2 | >0.05 |
III (n= 7) | hIL-2-Luffin P1 | 22.5 | 13.9 ± 2.1 | <0.001 |